Cargando…
Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium
The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953466/ https://www.ncbi.nlm.nih.gov/pubmed/36830989 http://dx.doi.org/10.3390/biomedicines11020453 |
_version_ | 1784893884840542208 |
---|---|
author | Pauna, Ana-Maria Raluca Mititelu Tartau, Liliana Bogdan, Maria Meca, Andreea-Daniela Popa, Gratiela Eliza Pelin, Ana Maria Drochioi, Cristian Ilie Pricop, Daniela Angelica Pavel, Liliana Lacramioara |
author_facet | Pauna, Ana-Maria Raluca Mititelu Tartau, Liliana Bogdan, Maria Meca, Andreea-Daniela Popa, Gratiela Eliza Pelin, Ana Maria Drochioi, Cristian Ilie Pricop, Daniela Angelica Pavel, Liliana Lacramioara |
author_sort | Pauna, Ana-Maria Raluca |
collection | PubMed |
description | The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofenac-loaded micro-vesicles coated with chitosan were prepared and physico-chemical analyzed. We investigated their in vitro hemocompatibility and in vivo biocompatibility in rats. The animals were treated orally as follows: group 1 (Control): distilled water 0.3 mL/100 g body weight; Group 2 (CHIT): 0.3 mL/100 g body weight 0.5% chitosan solution; Group 3 (DCF): 15 mg/kg body weight diclofenac; Group 4 (DCF-ves): lipid vesicles loaded with diclofenac 15 mg/kg body weight. Blood samples were collected for assessing: red blood cells, hemoglobin, hematocrit and leukocyte formula. A series of specific parameters of the liver and kidney function, some markers of immune defense, as well as the activity of some enzymes involved in oxidative processes, were also investigated. At the end of the experiment, the animals were sacrificed and fragments of liver, kidney and stomach were collected for histopathological examination. No blood hemolysis was evidenced by the in vitro test with the administration of diclofenac vesicles. The animals treated with diclofenac lipid vesicles stabilized with chitosan did not display any notable differences in their hematological and biochemical profile compared to control animals. These data correlated with the histological results, which showed the absence of architectural changes in the examined tissues. Biological in vitro and in vivo evaluation revealed that the microvesicles containing diclofenac are biocompatible, with potential to be used as delivery systems to modify the drug release, thus making them an attractive candidate for biomedical applications. |
format | Online Article Text |
id | pubmed-9953466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99534662023-02-25 Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium Pauna, Ana-Maria Raluca Mititelu Tartau, Liliana Bogdan, Maria Meca, Andreea-Daniela Popa, Gratiela Eliza Pelin, Ana Maria Drochioi, Cristian Ilie Pricop, Daniela Angelica Pavel, Liliana Lacramioara Biomedicines Article The purpose of our study was the obtaining, characterization and biocompatibility estimation of novel carrier systems for diclofenac. Diclofenac is a potent nonsteroidal anti-inflammatory drug with frequent gastrointestinal side effects, impairing the quality of the patient’s life. Original diclofenac-loaded micro-vesicles coated with chitosan were prepared and physico-chemical analyzed. We investigated their in vitro hemocompatibility and in vivo biocompatibility in rats. The animals were treated orally as follows: group 1 (Control): distilled water 0.3 mL/100 g body weight; Group 2 (CHIT): 0.3 mL/100 g body weight 0.5% chitosan solution; Group 3 (DCF): 15 mg/kg body weight diclofenac; Group 4 (DCF-ves): lipid vesicles loaded with diclofenac 15 mg/kg body weight. Blood samples were collected for assessing: red blood cells, hemoglobin, hematocrit and leukocyte formula. A series of specific parameters of the liver and kidney function, some markers of immune defense, as well as the activity of some enzymes involved in oxidative processes, were also investigated. At the end of the experiment, the animals were sacrificed and fragments of liver, kidney and stomach were collected for histopathological examination. No blood hemolysis was evidenced by the in vitro test with the administration of diclofenac vesicles. The animals treated with diclofenac lipid vesicles stabilized with chitosan did not display any notable differences in their hematological and biochemical profile compared to control animals. These data correlated with the histological results, which showed the absence of architectural changes in the examined tissues. Biological in vitro and in vivo evaluation revealed that the microvesicles containing diclofenac are biocompatible, with potential to be used as delivery systems to modify the drug release, thus making them an attractive candidate for biomedical applications. MDPI 2023-02-04 /pmc/articles/PMC9953466/ /pubmed/36830989 http://dx.doi.org/10.3390/biomedicines11020453 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pauna, Ana-Maria Raluca Mititelu Tartau, Liliana Bogdan, Maria Meca, Andreea-Daniela Popa, Gratiela Eliza Pelin, Ana Maria Drochioi, Cristian Ilie Pricop, Daniela Angelica Pavel, Liliana Lacramioara Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title | Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title_full | Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title_fullStr | Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title_full_unstemmed | Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title_short | Synthesis, Characterization and Biocompatibility Evaluation of Novel Chitosan Lipid Micro-Systems for Modified Release of Diclofenac Sodium |
title_sort | synthesis, characterization and biocompatibility evaluation of novel chitosan lipid micro-systems for modified release of diclofenac sodium |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953466/ https://www.ncbi.nlm.nih.gov/pubmed/36830989 http://dx.doi.org/10.3390/biomedicines11020453 |
work_keys_str_mv | AT paunaanamariaraluca synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT mititelutartauliliana synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT bogdanmaria synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT mecaandreeadaniela synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT popagratielaeliza synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT pelinanamaria synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT drochioicristianilie synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT pricopdanielaangelica synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium AT pavellilianalacramioara synthesischaracterizationandbiocompatibilityevaluationofnovelchitosanlipidmicrosystemsformodifiedreleaseofdiclofenacsodium |